Neuroendocrine Tumours Archives - Medical Conferences

177Lu-DOTATATE significantly extends PFS in patients with GEP-NETs, regardless of grade or origin

Presented By

Dr Simron Singh, University of Toronto, Canada

Trial

Phase 3, NETTER-2

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:56

NETTER-2: Practice-changing results for 177Lu-DOTATATE in GEP-NETs

Presented By

Dr Simron Singh, University of Toronto, Canada

Trial

Phase 3, NETTER-2

Conference

ASCO GI 2024

Type

News article

13 February 2024 13:03

Head-to-head: Etoposide and irinotecan equally effective in neuroendocrine carcinoma

Presented By

Dr Chigusa Morizane, National Cancer Center Hospital, Japan

Trial

Phase 3, JCOG1213, TOPIC-NEC

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:26

No benefit of adding axitinib to ocreotide acetate in non-pancreatic neuroendocrine tumours

Presented By

Dr Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Spain

Trial

Phase 3, AXINET trial-GETNE-1107

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 10:44

Phase 2 abemaciclib trial in patients with advanced NETs

Presented By

Prof. Kaylyn Kit Man Wong, University of Washington, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 10:39

Spread through air spaces is prognostic in lung neuroendocrine tumours

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 22:04

Prognostic value of distant organ-specific metastases in newly diagnosed lung neuroendocrine tumours

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 21:08